Timothy Hoey
Chief Tech/Sci/R&D Officer at TENAYA THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/04/2024
Timothy Hoey active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 | - |
Career history of Timothy Hoey
Former positions of Timothy Hoey
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/01/2016 | 01/01/2017 |
| Corporate Officer/Principal | 01/01/2005 | 01/01/2016 | |
| AMGEN INC. | Corporate Officer/Principal | - | 01/01/2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director/Board Member | - | 14/12/2011 |
| Corporate Officer/Principal | 14/12/2011 | - |
Training of Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Timothy Hoey
- Experience
